Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines: developed in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA).

[1]  Lawrence O Gostin,et al.  Reforming the HIPAA Privacy Rule: safeguarding privacy and promoting research. , 2009, JAMA.

[2]  Laura A. Levit,et al.  Beyond the HIPAA Privacy Rule: Enhancing Privacy, Improving Health Through Research. Washington, DC: National Academies Press , 2009 .

[3]  K. Ellenbogen,et al.  Downloadable Algorithm to Reduce Inappropriate Shocks Caused by Fractures of Implantable Cardioverter-Defibrillator Leads , 2008, Circulation.

[4]  Cristina Masella,et al.  Remote Monitoring of CRT‐ICD: The Multicenter Italian CareLink Evaluation—Ease of Use, Acceptance, and Organizational Implications , 2008, Pacing and clinical electrophysiology : PACE.

[5]  W. Maisel,et al.  Proceedings of the ICD Lead Performance Conference. , 2008, Heart rhythm.

[6]  B. Lindsay,et al.  Review of the Registry's second year, data collected, and plans to add lead and pediatric ICD procedures. , 2008, Heart rhythm.

[7]  C. Gornick,et al.  Failure of impedance monitoring to prevent adverse clinical events caused by fracture of a recalled high-voltage implantable cardioverter-defibrillator lead. , 2008, Heart rhythm.

[8]  S. Priori,et al.  HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. , 2008, Heart rhythm.

[9]  J. Ornato,et al.  ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2008, Heart rhythm.

[10]  W. Maisel,et al.  Implantable cardioverter-defibrillator lead performance. , 2008, Circulation.

[11]  J. Eckstein,et al.  Necessity for Surgical Revision of Defibrillator Leads Implanted Long-Term: Causes and Management , 2008, Circulation.

[12]  Harlan M Krumholz,et al.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Journal of the American College of Cardiology.

[13]  J. Triedman,et al.  Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. , 2008, Journal of the American College of Cardiology.

[14]  Jacques Victor,et al.  Risk Factors Related to Infections of Implanted Pacemakers and Cardioverter-Defibrillators: Results of a Large Prospective Study , 2007, Circulation.

[15]  W. Maisel,et al.  Transvenous implantable cardioverter-defibrillator leads: the weakest link. , 2007, Circulation.

[16]  Thomas Kleemann,et al.  Annual Rate of Transvenous Defibrillation Lead Defects in Implantable Cardioverter-Defibrillators Over a Period of >10 Years , 2007, Circulation.

[17]  Joseph S Alpert,et al.  Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines Endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) and the International Coalition of Pacing and Electrophysiology Organizations (COPE). , 2006, Heart rhythm.

[18]  K. Ellenbogen,et al.  Management of recalled pacemakers and implantable cardioverter-defibrillators: a decision analysis model. , 2006, JAMA.

[19]  A. Krahn,et al.  Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. , 2006, JAMA.

[20]  J. Kirkpatrick,et al.  Postmortem analysis and retrieval of implantable pacemakers and defibrillators. , 2006, The New England journal of medicine.

[21]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[22]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[23]  Eric Fain,et al.  Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. , 2004, The New England journal of medicine.

[24]  J. Schroeder,et al.  Effects of Cardiac Resynchronization on Disease Progression in Patients With Left Ventricular Systolic Dysfunction, an Indication for an Implantable Cardioverter-Defibrillator, and Mildly Symptomatic Chronic Heart Failure , 2004, Circulation.

[25]  John K Triedman,et al.  Patient, procedural, and hardware factors associated with pacemaker lead failures in pediatrics and congenital heart disease. , 2004, Heart rhythm.

[26]  Hugh Calkins,et al.  Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. , 2004, The New England journal of medicine.

[27]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[28]  W. Maisel.  Physician Management of Pacemaker and Implantable Cardioverter Defibrillator Advisories , 2004, Pacing and clinical electrophysiology : PACE.

[29]  L. M. Beauregard,et al.  Personal Security: , 2004, Pacing and clinical electrophysiology : PACE.

[30]  J. Nielsen,et al.  A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: echocardiographic and clinical outcome. , 2003, Journal of the American College of Cardiology.

[31]  J. Daubert,et al.  Long-term improvements in quality of life by biventricular pacing in patients with chronic heart failure: results from the Multisite Stimulation in Cardiomyopathy study (MUSTIC). , 2003, The American journal of cardiology.

[32]  D. Delurgio,et al.  Effect of Cardiac Resynchronization Therapy on Left Ventricular Size and Function in Chronic Heart Failure , 2003, Circulation.

[33]  Uwe Dorwarth,et al.  Transvenous Defibrillation Leads: High Incidence of Failure During Long‐Term Follow‐Up , 2003, Journal of cardiovascular electrophysiology.

[34]  R. Kerber,et al.  ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices , 2002 .

[35]  R. Kerber,et al.  ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). , 2002, Circulation.

[36]  Thomas Lavergne,et al.  Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. , 2002, Journal of the American College of Cardiology.

[37]  L. Goldman,et al.  Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. , 2002, The New England journal of medicine.

[38]  Victor Parsonnet,et al.  Long‐Term Structural Failure of Coaxial Polyurethane Implantable Cardioverter Defibrillator Leads , 2002, Pacing and clinical electrophysiology : PACE.

[39]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[40]  J. Ilvento,et al.  Short and Medium Time Experience with a Tined, Multilumen Steroid Eluting Defibrillation Lead , 2002, Journal of Interventional Cardiac Electrophysiology.

[41]  Rebecca Herold,et al.  Standards for privacy of individually identifiable health information. Office of the Assistant Secretary for Planning and Evaluation, DHHS. Final rule. , 2001, Federal register.

[42]  D L Luebke,et al.  Advances in pacemaker technology. , 2001, Critical care nurse.

[43]  S. Chugh,et al.  Predictors and mode of detection of transvenous lead malfunction in implantable defibrillators. , 2001, The American journal of cardiology.

[44]  S. Connolly,et al.  Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. , 2000, European heart journal.

[45]  R. Cappato,et al.  Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). , 2000, Circulation.

[46]  M. Stanton,et al.  Prospective Postmarket Device Studies Versus Returned Product Analysis as a Predictor of System Survival , 2000, Pacing and clinical electrophysiology : PACE.

[47]  M Gent,et al.  Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes , 2000 .

[48]  M Gent,et al.  Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. , 2000, Circulation.

[49]  K. Lee,et al.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.

[50]  J. Brinker,et al.  Risks of spontaneous injury and extraction of an active fixation pacemaker lead: report of the Accufix Multicenter Clinical Study and Worldwide Registry. , 1999, Circulation.

[51]  T. D. Sellers,et al.  Initial experience with larger laser sheaths for the removal of transvenous pacemaker and implantable defibrillator leads. , 1999, Circulation.

[52]  P. J. Wang,et al.  Comparison of frequency of complications of implantable cardioverter-defibrillators in children versus adults. , 1999, The American journal of cardiology.

[53]  T. Gross,et al.  Improving patient care by reporting problems with medical devices. , 1998, Journal of toxicology. Clinical toxicology.

[54]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[55]  A. Moss,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.

[56]  L. Thuesen,et al.  Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome , 1994, The Lancet.

[57]  D. Hayes,et al.  Report of the Policy Conference of NASPE on device/lead performance and the development of a postmarket surveillance database. The Writing Committee. , 1993, Pacing and clinical electrophysiology : PACE.

[58]  David L Hayes,et al.  Do abandoned leads pose risk to implantable cardioverter-defibrillator patients? , 2009, Heart rhythm.

[59]  William T. Abraham,et al.  Writing Committee Members , 2008 .

[60]  Wataru Shimizu,et al.  Long-term follow-up of transvenous defibrillation leads: high incidence of fracture in coaxial polyurethane lead. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[61]  M. Field,et al.  Safe medical devices for children , 2006 .

[62]  Tim Vaughn,et al.  Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications. , 2003, Journal of the American College of Cardiology.

[63]  B. Wilkoff,et al.  Lead- and device-related complications in the antiarrhythmics versus implantable defibrillators trial. , 2001, American heart journal.